Showing results (51-60 of 92) with videos related to
Sort By:
Pageof 10
World Journal of Gastroenterology|January 17, 2015
Butein effects in colitis and interleukin-6/signal transducer and activator of transcription 3 expressionSehe Dong Lee, Jung Wan Choe, Beom Jae Lee, et al.Scandinavian Journal of Gastroenterology|July 30, 2008
Chronic cirrhotic hepatitis B patients with a high incidence of hepatic decompensation after viral breakthrough with lamivudine-resistant mutants and during rescue treatmentMoon Kyung Joo, Jong Eun Yeon, Ji Hoon Kim, et al.Pancreas|December 10, 2015
Value of Early Check-Up of Carbohydrate Antigen 19-9 Levels for Pancreatic Cancer Screening in Asymptomatic New-Onset Diabetic PatientsJung Wan Choe, Jae Seon Kim, Hyo Jung Kim, et al.World Journal of Gastrointestinal Endoscopy|April 27, 2016
Application of the Prague C and M criteria for endoscopic description of columnar-lined esophagus in South KoreaJung Wan Choe, Young Choon Kim, Moon Kyung Joo, et al.Digestive Diseases and Sciences|November 14, 2009
Long-term outcomes of prophylactic endoscopic histoacryl injection for gastric varices with a high risk of bleedingYun Jung Chang, Jong-Jae Park, Moon Kyung Joo, et al.The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi|January 25, 2005
[Expression of epidermal growth factor receptor, ErbB2 and matrix metalloproteinase-9 in hepatolithiasis and cholangiocarcinoma]Hyo Jung Kim, Jae Seon Kim, Chang Don Kang, et al.Gut and Liver|December 5, 2014
The influence of alcoholic liver disease on serum PIVKA-II levels in patients without hepatocellular carcinomaKeun Hee Kang, Ji Hoon Kim, Seong Hee Kang, et al.Journal of Gastroenterology and Hepatology|December 13, 2005
Factors related to post-treatment relapse in chronic hepatitis B patients who lost HBeAg after lamivudine therapyKwan Soo Byun, Oh Sang Kwon, Ju Hyun Kim, et al.Scandinavian Journal of Gastroenterology|November 11, 2008
Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolizationJeong Han Kim, Ji Hoon Kim, Jong Hwan Choi, et al.Journal of Gastroenterology and Hepatology|January 4, 2008
PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymesYeon Seok Seo, Ji Hoon Kim, Nam Young Jo, et al.Pageof 10